This is the first book to examine how effectively American and supranational EU governments have regulated innovative pharmaceuticals during the last 30 years regarding public health. It explains why pharmaceutical regulation has been misdirected by commercial interests and misconceived ideologies.

Autorentext
Courtney Davis is Senior Lecturer in Sociology at Kings College London, UK. Previously Director of the Centre for Corporate Accountability, she is author of Making Companies Safe.

John Abraham is Professor of Sociology at Kings College London, UK. Author of over 100 publications on pharmaceuticals in society, he was Special Expert Adviser to the UK House of Commons Health Select Committee Inquiry into the influence of the pharmaceutical industry (2005).

Inhalt

1. Putting Pharmaceutical Regulation to the Test: A Social Science for Public Health 2. The Political Economy of 'Innovative' Drug Regulation in the Neo-Liberal Era 3. Designs on Diabetes Drugs 4. Desperate Regulation for Desperate Cancer Patients 5. The Making of a Harmful 'Therapeutic Breakthrough' 6. The Regulatory Science and Politics of Risk Management 7. Conclusions and Policy Implications